Response to FDA draft guidance on pediatric IBD drug approval trials: A consensus statement from the IBD Porto Group
PMID: 39564649
Source: J Pediatr Gastroenterol Nutr
DOI:
10.1002/jpn3.12395
Publication date:
2024-11-20
Year:
2025
Abstract
NULL